This country profile provides an overview of Malawi’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
74%
Bilharzia
94%
River blindness
87%
6.9 million
people received treatment in Malawi in 2019
5.5 million
people did not receive treatment in Malawi in 2019
Elephantiasis
Malawi is conducting post-preventive chemotherapy surveillance.
Blinding trachoma
Malawi is conducting post-preventive chemotherapy surveillance.
Intestinal worms
Treatment coverage increased from 58% in 2018 to 74% in 2019.
Pre-sch and school-aged children needing treatment
7.41m
Pre-school and school-aged children receiving treatment
5.49m
Bilharzia
Treatment coverage decreased from 100% in 2018 to 94% in 2019.
School-aged children needing treatment
4.22m
School-aged children receiving treatment
3.96m
River blindness
Treatment coverage increased from 83% in 2018 to 87% in 2019.
People needing treatment
2.43m
People receiving treatment
2.13m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Malawi.